Tadaaki Yamada   Yasuhiro Goto   Hiroshi Tanaka   Hideharu Kimura   Koichi Minato   Hiroshi Gyotoku   Takeshi Honda   Satoshi Watanabe   Kenji Morimoto   Fumiaki Kiyomi   Junji Uchino   Koichi Takayama   
European journal of cancer (Oxford, England : 1990) 195 113373-113373 2023年10月 [査読有り]
BACKGROUND: Although concurrent chemoradiotherapy (CCRT) followed by durvalumab is the standard treatment for patients with stage III non-small cell lung cancer (NSCLC), only half of the patients are allowed to receive CCRT in real-world settings....